Page contentsKey factsDecisionTopicsKey facts Active Substance Masitinib mesilate Therapeutic area Oncology Decision number P/0104/2012 PIP number EMEA-001266-PIP01-12 Pharmaceutical form(s) Film-coated tablet Condition(s) / indication(s) Treatment of gastro-intestinal stromal tumours Route(s) of administration Oral use Contact for public enquiries AB ScienceFrancea.moussy@ab-science.com +33 147200014+33 147202411 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 01/06/2012DecisionP/104/2012: EMA decision of 1 June 2012 on the granting of a product specific waiver for masitinib (mesylate), (EMEA-001266-PIP01-12)AdoptedReference Number: EMA/331927/2012 English (EN) (118.75 KB - PDF)First published: 19/07/2012Last updated: 19/07/2012ViewTopicsPaediatricsShare this page